Skip to content

Effects of Daily Dark Chocolate Supplementation on Arterial Stiffness Induced by High-Intensity Resistance Training in Women

Effects of Daily Dark Chocolate Supplementation on Arterial Stiffness Induced by High-Intensity Resistance Training in Women During the Early Follicular Phase: A Double-Blind Randomized Placebo-Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000014358
Enrollment
29
Registered
2026-01-06
Start date
2024-09-24
Completion date
2024-10-24
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aims to investigate whether combining high-intensity resistance training with daily dark chocolate consumption can improve vascular health in healthy adults. Participants will complete a 4-week exercise program while consuming either 85% dark chocolate or a placebo. The study will measure arterial stiffness, blood pressure, and blood markers related to vascular function before and after the intervention.

Interventions

Intervention 1: High-Intensity Resistance Training (HIRT) + 85% Dark Chocolate Supplementation Physical or informational materials used: Participants received 25 g of 85% dark chocolate (DiRaja Chocolate, Pingtung County, Taiwan) daily for four weeks. Each serving contained approximately 1092.5 mg total cocoa flavanols (including catechin = 164.9 mg; epicatechin = 94.2 mg). Nutrition facts were confirmed by an accredited lab (OHC Lab, Taiwan). Exercise sessions were performed in a controlled lab

Intervention 1: High-Intensity Resistance Training (HIRT) + 85% Dark Chocolate Supplementation Physical or informational materials used: Participants received 25 g of 85% dark chocolate (DiRaja Chocolate, Pingtung County, Taiwan) daily for four weeks. Each serving contained approximately 1092.5 mg total cocoa flavanols (including catechin = 164.9 mg; epicatechin = 94.2 mg). Nutrition facts were confirmed by an accredited lab (OHC Lab, Taiwan). Exercise sessions were performed in a controlled laboratory gym at National Chung Cheng University. Training equipment included standard Olympic barbells and weight plates. Procedures, activities, and processes: Participants completed a 4-week high-intensity resistance training (HIRT) program, three sessions per week. Each session included: deadlift, bench press, and squat, performed at 75% 1RM, 5 sets × 6 repetitions, 3 min rest between sets, and 5 min rest between exercises. Warm-up and stretching were completed before each session. Participants consumed the chocolate daily after lunch and before dinner, avoiding other flavanol-rich foods. Pre- and post-tests (vascular and cardiovascular assessments) were scheduled during the early follicular phase (cycle days 2–5) to control for hormonal variation. Who delivered the intervention and their expertise: Exercise sessions were supervised one-on-one by trained research staff with qualifications in exercise physiology and resistance training (NSCA guidelines). Dietary control and supplement distribution were managed by research assistants trained in nutrition monitoring. Mode of delivery: HIRT sessions were delivered face-to-face, individually, in the university gym. Chocolate supplementation was self-administered at home with daily adherence monitoring. Frequency, duration, and schedule: Exercise: 3 sessions per week × 4 weeks (total = 12 sessions). Each session lasted approximately 60 minutes. Supplementation: 25 g dark chocolate daily for 28 days. Location: Laboratory gym, Department of Athletic Sports, National Chung Cheng University, Chiayi, Taiwan. Personalisation or adaptation: 1RM strength values were reassessed after 4 weeks and increased by 10% to adjust for expected strength gains (maintaining 75% intensity). Adherence and fidelity: Exercise attendance recorded by research staff. Supplement adherence verified by return of empty chocolate wrappers and daily intake logs. Participants received daily reminders and weekly check-ins to maintain compliance.

Sponsors

National Science and Technology Council (NSTC)
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy adult women aged 18–30 years. Regular menstrual cycles, defined as: Cycle length between 21–35 days in the past 3 months. Menstrual bleeding duration of 4–7 days.

Exclusion criteria

(1) Irregular menstrual cycles (cycle length < 21 days or > 35 days in the past 3 months, or menses not lasting between 4–7 days) (2) Pregnancy or lactation within the past year (3) History of cardiovascular or gynecological surgery within the past 6 months (4) Long-term use of oral contraceptives or other hormone-related medications (5) Smoking or habitual alcohol consumption; Hypertension (SBP > 140 mmHg or DBP > 90 mmHg), chronic illness, cardiovascular disease, or other heart-related conditions (6) Allergy to cocoa products, nuts, or fruits (7) Regular intake of flavanol-rich foods (e.g., tea, chocolate, apples), which may interfere with the effects of dark chocolate.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026